Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements published on April 11, 2023 in the columns of English daily 'Financial Express', all editions and Punjabi daily 'Rozana Spokesman', Mohali edition, inter-alia, intimating completion of the electronic transmission of Postal Ballot Notice along with the Postal Ballot Form to the Members.
11-04-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR), this is to inform you that the Company has completed dispatch of postal ballot notice to its members on April 10, 2023 for seeking their approval on the following proposals: a) To consider appointment of Mr. Tomo Nagahiro (DIN: 10074111) as a Non-Executive Director of the Company; and b) To consider appointment of Mr. Mehmet Ali Aydinlar (DIN: 10073483) as a Non-Executive Director of the Company. Further, a copy of the Postal Ballot Notice along with Ballot Form is enclosed for kind reference.
10-04-2023

Medanta, Fortis hospitals asked to keep 20% beds for BPL, EWS families

 Families falling under the BPL and the EWS will now get medical facilities in Medanta and Fortis hospitals in Gurugram, as per an initiative taken by the district administration
01-04-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Closure of Trading Window

 With reference to the provisions of Policy / Code of Conduct for Prevention of Insider Trading, the "Trading Window" for dealing in shares of the Company is closed from March 31, 2023 till 48 hours from declaration of financial results for the financial year ending on March 31, 2023.
30-03-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), this is to further inform you that Mr. Takeshi Saito (DIN: 08823345) and Dr. Farid Bin Mohamed Sani (DIN: 08646785) have resigned from the position of Non-Executive & Non-Independent Directors of the Company and accordingly, they have ceased to be Directors of the Company with effect from today i.e. March 28, 2023 (close of business hours). The detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/ CFD /CMD/4/2015 dated September 9, 2015 is enclosed as Annexure-A.
28-03-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Pursuant to Regulation 30 of the SEBI LODR Regulations, 2015, this is to inform you that based on the recommendation of the Nomination and Remuneration Committee of the Company, the Board of Directors of the Company vide a circular resolution passed on March 28, 2023 has approved the appointment of Mr. Mehmet Ali Aydinlar (DIN: 10073483) and Mr. Tomo Nagahiro (DIN: 10074111), as Additional Directors (Non-Executive & Non-Independent) of the Company with effect from March 28, 2023. This is to further inform you that Mr. Takeshi Saito (DIN: 08823345) and Dr. Farid Bin Mohamed Sani (DIN: 08646785) have resigned from the position of Non-Executive & Non-Independent Directors of the Company and accordingly, they have ceased to be Directors of the Company with effect from today i.e. March 28, 2023 (close of business hours). The detailed disclosure as required under Regulation 30 of LODR read with SEBI Circular No. CIR/ CFD /CMD/4/2015 dtd Sept 9, 2015 is enclosed as Annex-A.
28-03-2023

Max, KKR in talks with TPG to buy Care Hospitals

 If a deal takes place, this will be the second-largest hospital buyout in India after the IHH-Fortis transaction of 2018.
10-03-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), this is to inform you that Dr. Kelvin Loh Chi-Keon (DIN: 08515101) has resigned from the position of Non-Executive & Non-Independent Director of the Company with effect from February 22, 2023. Further, he has also resigned from the position of Non-Executive Director of SRL Limited, material subsidiary of the Company, with effect from said date. The detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/ CFD /CMD/4/2015 dated September 9, 2015 is enclosed.
23-02-2023

Reliance group's Tony Jesudasan suffers heart attack, passes away at 71

 Tony Jesudasan, a key lieutenant of Anil Ambani's Reliance group and one of the finest corporate communications and corporate affairs professionals, died early on Monday morning. He was 71. Earlier this month, Jesudasan had suffered a heart attack just as he took a flight from Bhopal, sources said. He was rushed to Fortis Hospital on arrival in Delhi, where he underwent angioplasty. He was then shifted to Medanta Hospital in Gurugram. He continued to be in critical care till his passing away at around 5 am on Monday, they said. He is survived by wife Parul Sharma and daughter Preetika. Jesudasan, or TJ as he was referred to by friends, turned 71 while he was at Fortis. He was group president for corporate communications and corporate affairs of R-ADAG. An MBA from FMS, Delhi, he was invited by Dhirubhai Ambani to join the then undivided Reliance in 1990. After the death of Dhirubhai, he chose to join the younger sibling when brothers Mukesh and Anil split. He remained Anil Ambani
20-02-2023
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Transcript of the investors / analysts meet held on February 13, 2023 to discuss the Company's un-audited financial results for the quarter ended December 31, 2022. Further, the said transcript is also available on the website of the Company i.e. https://www.fortishealthcare.com/investors.
16-02-2023
Next Page
Close

Let's Open Free Demat Account